Phase 4 N=23,687 Continuous Chest Compressions vs AHA Standard CPR of 30:2
Out of Hospital Cardiac Arrest
Primary: Number of Participants Who Survive From the Time of Cardiac Arrest to Hospital Discharge — 1072; 1127 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=6,208 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Asthma
Primary: Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal…
Phase 4 N=111 Treatment of Peripheral T-cell Lymphoma
Peripheral T-cell Lymphoma
Primary: Progression-free Survival — 35; 27 participants
Phase 4 N=6,586 An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Primary: Percentage of Participants With Objective Response According to Response Evaluation Criteria in Solid Tumors (RECIST) — 11 percentage of participants
Phase 4 N=10 Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
Major Depression
Primary: 17-item Hamilton Depression Rating Scale — 19; 10 units on a scale
Phase 4 N=20 Brain Imaging of Quetiapine Response in Anxious Depression
Major Depression
Primary: 17-item Hamilton Depression Rating Scale (HDRS) — 20; 8 units on a scale
Phase 4 N=240 Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis
Candidiasis, Vulvovaginal
Primary: Therapeutic Efficacy 1 — 102; 98 participants — p=0.925
Phase 4 N=24 Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
Crohn's Disease
Primary: Endoscopic Recurrence: the Proportion of Patients in Endoscopic Recurrence at One Year — 1; 11 participants — p=.0005
Phase 4 N=114 Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain
Osteoarthritis · Rheumatoid Arthritis · Lower Back Pain
Primary: Efficacy According to BS-11 Pain Score Reduction — 2.7 units on a scale
Phase 4 N=8 A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
Psoriasis
Primary: Investigator Global Assessment — 1.13 units on a scale
Phase 4 N=3 An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.
Attention Deficit Hyperactivity Disorder
Primary: Change in Adult Investigator Symptom Rating Scale (AISRS) Scores From Baseline — -5 Units on a scale
Phase 4 N=1 An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
Friedreich Ataxia
Primary: International Cooperative Ataxia Rating Scale (ICARS) — 39; 30; 47; 46 units
Phase 4 N=243 An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)
Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
Primary: Percentage of Participants With Cardiac and Liver Iron Overload. — 10; 22; 4; 0 Percentage of participants
Phase 4 N=190 Ipratropium Bromide in Peri-Operative COPD
Pulmonary Disease, Chronic Obstructive
Primary: Change of Forced Expiratory Volume in 1 Second (FEV1) From Pre-bronchodilator at Baseline to Post-nebulization One Day Before the Surgery — 169.9; 15.0 ml — p=<0.0001
Phase 4 N=252 The Bioseal Vascular Study
Cardiovascular Bleeding · Vascular Bleeding · Hemorrhage
Primary: Hemostasis at the Target Bleeding Site (TBS) at 10 Minutes Following the Completion of Treatment Application. — 96; 88.2 percentage of patients